Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction

Abstract Aims Improving the health status (symptoms, function, and quality of life) of patients with heart failure with reduced ejection fraction (HFrEF) is a primary treatment goal. Angiotensin receptor neprilysin inhibitors (ARNI) improve short‐term health status in clinical practice, but the sust...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Merrill Thomas, Yevgeniy Khariton, Gregg C. Fonarow, Suzanne V. Arnold, Larry Hill, Michael E. Nassif, Paul S. Chan, Javed Butler, Laine Thomas, Adam D. DeVore, Adrian F. Hernandez, Nancy M. Albert, J. Herbert Patterson, Fredonia B. Williams, John A. Spertus
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Oxford University Press 2021-08-01
Reeks:	ESC Heart Failure
Onderwerpen:	Heart failure reduced ejection fraction Quality of life Health status Angiotensin‐neprilysin inhibitor
Online toegang:	https://doi.org/10.1002/ehf2.13298
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!